Related Experiment Video
Updated: Jun 30, 2025
Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
Published on: February 17, 2016
MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor
Océane Perdaens1, Pauline Bottemanne2, Vincent van Pesch1,3
1Neurochemistry Group, Institute of NeuroScience, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Introduction:
Demyelination is one of the hallmarks of multiple sclerosis (MS). While remyelination occurs during the disease, it is incomplete from the start and strongly decreases with its progression, mainly due to the harm to oligodendrocyte progenitor cells (OPCs), causing irreversible neurological deficits and contributing to neurodegeneration. Therapeutic strategies promoting remyelination are still very preliminary and lacking within the current treatment panel for MS.
Methods:
In a previous study, we identified 21 microRNAs dysregulated mostly in the CSF of relapsing and/or remitting MS patients. In this study we transfected the mimics/inhibitors of several of these microRNAs separately in an OPC cell line, called CG-4. We aimed (1) to phenotypically characterize their effect on OPC differentiation and (2) to identify corroborating potential mRNA targets via immunocytochemistry, RT-qPCR analysis, RNA sequencing, and Gene Ontology enrichment analysis.
Results:
We observed that the majority of 13 transfected microRNA mimics decreased the differentiation of CG-4 cells. We demonstrate, by RNA sequencing and independent RT-qPCR analyses, that miR-33-3p, miR-34c-5p, and miR-124-5p arrest OPC differentiation at a late progenitor stage and miR-145-5p at a premyelinating stage as evidenced by the downregulation of premyelinating oligodendrocyte (OL) [Tcf7l2, Cnp (except for miR-145-5p)] and mature OL (Plp1, Mbp, and Mobp) markers, whereas only miR-214-3p promotes OPC differentiation. We further propose a comprehensive exploration of their change in cell fate through Gene Ontology enrichment analysis. We finally confirm by RT-qPCR analyses the downregulation of several predicted mRNA targets for each microRNA that possibly support their effect on OPC differentiation by very distinctive mechanisms, of which some are still unexplored in OPC/OL physiology.
Conclusion:
miR-33-3p, miR-34c-5p, and miR-124-5p arrest OPC differentiation at a late progenitor stage and miR-145-5p at a premyelinating stage, whereas miR-214-3p promotes the differentiation of CG-4 cells. We propose several potential mRNA targets and hypothetical mechanisms by which each microRNA exerts its effect. We hereby open new perspectives in the research on OPC differentiation and the pathophysiology of demyelination/remyelination, and possibly even in the search for new remyelinating therapeutic strategies in the scope of MS.
Insights
Specific microRNAs impact oligodendrocyte progenitor cell differentiation in multiple sclerosis models. Some microRNAs inhibit differentiation, while miR-214-3p promotes it, offering potential therapeutic targets for remyelination.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Multiple sclerosis (MS) is characterized by demyelination, where remyelination is often incomplete and declines with disease progression.
- Damage to oligodendrocyte progenitor cells (OPCs) impairs remyelination, leading to neurological deficits and neurodegeneration.
- Current MS therapies lack strategies to promote remyelination effectively.
Purpose of the Study:
- To investigate the effects of dysregulated microRNAs on OPC differentiation.
- To identify potential mRNA targets of these microRNAs involved in OPC differentiation.
- To explore novel therapeutic avenues for promoting remyelination in MS.
Main Methods:
- Transfection of microRNA mimics/inhibitors into CG-4 OPC cell line.
- Phenotypic characterization of OPC differentiation.
- RNA sequencing and RT-qPCR for gene expression analysis.
- Immunocytochemistry and Gene Ontology enrichment analysis for target identification.
Main Results:
- Most tested microRNA mimics inhibited CG-4 cell differentiation.
- miR-33-3p, miR-34c-5p, and miR-124-5p arrested OPC differentiation at a late progenitor stage.
- miR-145-5p arrested differentiation at a premyelinating stage, while miR-214-3p promoted differentiation.
- Downregulation of key oligodendrocyte markers (e.g., Tcf7l2, Cnp, Plp1, Mbp) was observed with inhibitory microRNAs.
Conclusions:
- Specific microRNAs differentially regulate OPC differentiation, with some inhibiting and one promoting the process.
- Identified microRNAs and their potential mRNA targets offer insights into OPC differentiation mechanisms.
- These findings open new avenues for understanding MS pathophysiology and developing remyelination therapies.
